Psychotherapy Improves Mental Health But Not IBD Disease Activity
Psychological therapies have no effect on IBD disease activity despite beneficial effects on anxiety, depression, and QOL.
Source: neurologyadvisor.com
Page 11 - Controlled Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Controlled Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Controlled Trials Today - Breaking & Trending Today
Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough: A Systematic Review and Dose-Response Meta-Analysis | Otolaryngology | JAMA
This systematic review and dose-response meta-analysis evaluates the efficacy and tolerability of gefapixant, a new P2X3 antagonist, for the treatment of adults
Source: jamanetwork.com
IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease
FLORHAM PARK, N.J., September 07, 2023--Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcro
Source: yahoo.com
Somnolence, Insomnia Risk Higher With Antidepressant Use Compared With Placebo
The risk for sleep disturbances, including somnolence and insomnia, is an adverse event associated with antidepressant use.
Source: psychiatryadvisor.com
Noninvasive Brain Stimulation Can Ease Most Common MS Symptoms
The use of noninvasive brain stimulation treatments has a significant effect on the most common clinical symptoms in patients with MS.
Source: neurologyadvisor.com